541 related articles for article (PubMed ID: 10510388)
21. Immunotherapy of melanoma: a dichotomy in the requirement for IFN-gamma in vaccine-induced antitumor immunity versus adoptive immunotherapy.
Winter H; Hu HM; McClain K; Urba WJ; Fox BA
J Immunol; 2001 Jun; 166(12):7370-80. PubMed ID: 11390488
[TBL] [Abstract][Full Text] [Related]
22. Relative perforin- and Fas-mediated lysis in T1 and T2 CD8 effector populations.
Carter LL; Dutton RW
J Immunol; 1995 Aug; 155(3):1028-31. PubMed ID: 7543509
[TBL] [Abstract][Full Text] [Related]
23. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
Miura Y; Thoburn CJ; Bright EC; Hess AD
Biol Blood Marrow Transplant; 2004 Mar; 10(3):156-70. PubMed ID: 14993881
[TBL] [Abstract][Full Text] [Related]
24. A role for perforin in activation-induced T cell death in vivo: increased expansion of allogeneic perforin-deficient T cells in SCID mice.
Spaner D; Raju K; Rabinovich B; Miller RG
J Immunol; 1999 Jan; 162(2):1192-9. PubMed ID: 9916752
[TBL] [Abstract][Full Text] [Related]
25. Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells.
Shimizu M; Fontana A; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A
J Immunol; 1999 Jun; 162(12):7350-7. PubMed ID: 10358186
[TBL] [Abstract][Full Text] [Related]
26. Increased susceptibility to immune destruction of B16BL6 tumor cells engineered to express a novel pro-Smac fusion protein.
Rüttinger D; Li R; Poehlein CH; Haley D; Walker EB; Hu HM; Fox BA
J Immunother; 2008 Jan; 31(1):43-51. PubMed ID: 18157011
[TBL] [Abstract][Full Text] [Related]
27. Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand.
Liu AN; Mohammed AZ; Rice WR; Fiedeldey DT; Liebermann JS; Whitsett JA; Braciale TJ; Enelow RI
Am J Respir Cell Mol Biol; 1999 May; 20(5):849-58. PubMed ID: 10226053
[TBL] [Abstract][Full Text] [Related]
28. IFN-gamma promotes Fas ligand- and perforin-mediated liver cell destruction by cytotoxic CD8 T cells.
Roth E; Pircher H
J Immunol; 2004 Feb; 172(3):1588-94. PubMed ID: 14734739
[TBL] [Abstract][Full Text] [Related]
29. Independent roles of perforin, granzymes, and Fas in the control of Friend retrovirus infection.
Zelinskyy G; Balkow S; Schimmer S; Schepers K; Simon MM; Dittmer U
Virology; 2004 Dec; 330(2):365-74. PubMed ID: 15567431
[TBL] [Abstract][Full Text] [Related]
30. IL-2 induces Fas ligand/Fas (CD95L/CD95) cytotoxicity in CD8+ and CD4+ T lymphocyte clones.
Esser MT; Dinglasan RD; Krishnamurthy B; Gullo CA; Graham MB; Braciale VL
J Immunol; 1997 Jun; 158(12):5612-8. PubMed ID: 9190908
[TBL] [Abstract][Full Text] [Related]
31. Ca2+-dependent, Fas- and perforin-independent apoptotic death of allografted tumor cells by a type of activated macrophage.
Yoshida R; Sanchez-Bueno A; Yamamoto N; Einaga-Naito K
J Immunol; 1997 Jul; 159(1):15-21. PubMed ID: 9200433
[TBL] [Abstract][Full Text] [Related]
32. Costimulation of tumor-reactive CD4+ and CD8+ T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma.
Li Y; McGowan P; Hellström I; Hellström KE; Chen L
J Immunol; 1994 Jul; 153(1):421-8. PubMed ID: 7515929
[TBL] [Abstract][Full Text] [Related]
33. CD8+ T cells mediate aortic allograft vasculopathy by direct killing and an interferon-gamma-dependent indirect pathway.
Skaro AI; Liwski RS; Zhou J; Vessie EL; Lee TD; Hirsch GM
Cardiovasc Res; 2005 Jan; 65(1):283-91. PubMed ID: 15621057
[TBL] [Abstract][Full Text] [Related]
34. Two types of anti-TL (thymus leukemia) CTL clones with distinct target specificities: differences in cytotoxic mechanisms and accessory molecule requirements.
Tsujimura K; Takahashi T; Iwase S; Matsudaira Y; Kaneko Y; Yagita H; Obata Y
J Immunol; 1998 Jun; 160(11):5253-61. PubMed ID: 9605121
[TBL] [Abstract][Full Text] [Related]
35. Evidence of alternative or concomitant use of perforin- and Fas-dependent pathways in a T cell-mediated negative regulation of Ig production.
Majlessi L; Bordenave G
J Immunol; 1999 Apr; 162(8):4391-8. PubMed ID: 10201974
[TBL] [Abstract][Full Text] [Related]
36. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells.
Brandau S; Suttmann H; Riemensberger J; Seitzer U; Arnold J; Durek C; Jocham D; Flad HD; Böhle A
Clin Cancer Res; 2000 Sep; 6(9):3729-38. PubMed ID: 10999767
[TBL] [Abstract][Full Text] [Related]
37. T cell-mediated, IFN-gamma-facilitated rejection of murine B16 melanomas.
Böhm W; Thoma S; Leithäuser F; Möller P; Schirmbeck R; Reimann J
J Immunol; 1998 Jul; 161(2):897-908. PubMed ID: 9670968
[TBL] [Abstract][Full Text] [Related]
38. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells.
Dao T; Mehal WZ; Crispe IN
J Immunol; 1998 Sep; 161(5):2217-22. PubMed ID: 9725214
[TBL] [Abstract][Full Text] [Related]
39. NK cells rapidly remove B16F10 tumor cells in a perforin and interferon-gamma independent manner in vivo.
Grundy MA; Zhang T; Sentman CL
Cancer Immunol Immunother; 2007 Aug; 56(8):1153-61. PubMed ID: 17160409
[TBL] [Abstract][Full Text] [Related]
40. Cytokine-deficient CD8+ Tc1 cells induced by IL-4: retained inflammation and perforin and Fas cytotoxicity but compromised long term killing of tumor cells.
Sad S; Li L; Mosmann TR
J Immunol; 1997 Jul; 159(2):606-13. PubMed ID: 9218575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]